Arthneeti
Sale is live|00:00:00
IRIS Regtech Solutions LtdQ3 FY23

IRIS Regtech Solutions Ltd Q3 FY23 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: 244P/E: 34.1Market Cap: ₹483 CrSector: IT - Software

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

Yes

Order

N/A

Capex

N/A

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3
  • Growth is expected to be driven by new mandates such as ESG reporting, particularly in markets like Europe and the US government reporting domain.
  • The Create segment showed robust growth of 46%, with good profitability and scale economics improving margins.
  • The Collect segment growth has been stagnant but potential exists as regulatory mandates roll out.
  • Expansion into replacement markets by targeting customers using inefficient or pricier solutions.
  • Introduction of new products like the Disclosure Management platform and Litigation Management System to tap adjacent markets.
  • Early adoption by customers and ongoing feedback loops expected to stabilize and ramp offerings within a year.
  • Continued focus on winning government tenders and scaling regulated markets as mandates unfold gradually.
  • Management remains optimistic about a gradual ramp-up in regulatory-driven demand and replacement market opportunities.
  • Investment in senior resources and technology platforms shows confidence in future growth potential.

Margin guidance

Category 3
  • IRIS sees growth opportunities primarily from new mandates like US government reporting and ESG initiatives in Europe starting next year.
  • Create segment showed robust 46% growth with improving profitability due to scale economies and increased platform usage.
  • Collect segment revenue growth is slower, affected by regulator delays, but expected to improve with new tenders expected by December.
  • ESG filings under SEBI are increasing, indicating a ramp-up in XBRL adoption and potential growth.
  • The company is investing in senior hires and marketing to drive growth, signaling confidence despite current cautious cash flow.
  • Attrition, especially at senior level, remains a key challenge affecting growth and operational efficiency.
  • Management cautions that growth is linked to regulatory timelines which are uncertain, with some mandates only expected to materialize next fiscal year.
  • Overall, the outlook is cautiously optimistic with targeted initiatives and new product launches expected to drive earnings and profitability expansion.

3 more insights locked — sign up free to unlock

Fundraise plans

Yes
  • The company is on the borderline regarding a rights issue, which was initially aimed at managing attrition and investing in growth.
  • Promoters currently do not have the funds to subscribe to the rights issue; hence, the rights issue remains in a state of uncertainty.
  • There is a perception risk if promoters do not participate in the rights issue, but the company maintains integrity and transparency about the situation.
  • No concrete decision has been made yet; the company is in a "quandary" but is "bordering on tilting towards" not proceeding with the rights issue.
  • There is no mention of new debt fundraising in the transcript.
  • The company continues to focus on organic growth and managing cash flows prudently, including hiring senior resources despite cash constraints, signaling confidence in future growth.

Order book

  • The company is currently bidding on four projects, but specific timelines for decisions are unknown.
  • There is no clear clarity on the budget cycles of these projects, making it difficult to predict when orders will materialize.
  • Some tenders and RFP screening by regulators have started, but actual scaling and implementations are awaited.
  • The company has not lost any existing orders but has not won new significant orders recently; the situation is described as being "Trishanku is still hanging in the sky."
  • Delays in some regulatory mandates and implementations, such as the iFile project and GST-related systems, affect order inflow timing.
  • Optimism exists that some of these orders or mandates may come through by December, but definite timelines remain uncertain.
  • Integration and testing phases for some offerings, such as e-invoice IRP system, are ongoing with expected go-live in early December.

Capex plans

  • No explicit mention of current or future capital expenditure (capex) or strategic investments detailed in the transcript.
  • The company emphasizes cautious capital use, noting that some growth initiatives (e.g., US government reporting, ESG in Europe) can happen "without too much capital" as they "muddle along."
  • Discussion on rights issue highlights promoter constraints in subscribing due to lack of capital; no final decision yet on proceeding.
  • The company has hired senior personnel at high cost, indicating investment in talent as a strategic move signaling confidence in growth.
  • Focus is more on organic growth through technology innovation, new product launches (e.g., IRIS Litigation Management System, disclosure management platform), and developing markets rather than large capex or acquisitions.
  • No mention of imminent large-scale investments or capital-intensive projects; emphasis is placed on scalability of existing platforms and gradual market expansion.

How does IRIS Regtech Solutions Ltd rank vs peers in IT - Software?

Pro feature
1IRIS Regtech Solutions Ltd
Rev 3Mar 3

See full IT - Software sector rankings